Cytopeia

Calculating rank

USPTO Granted Patents = 4

Trademarks = 1

Forward Citations = 16

Loading Chart...

2 inventors (with patents filed for the assignee):

Ger Van Den Engh (3 out of 15 patents)

Gerrit Jan Van Den Engh (1 out of 13 patents)

4 patents: Sort by Forward Citations

1. 8223445 - Lens positioning apparatus (2012-07-17),

2. 7728974 - Enhanced detection system and method (2010-06-01),

3. 7643142 - Apparatus for analyzing and sorting biological particles (2010-01-05),

4. 7345758 - Apparatus for analyzing and sorting biological particles (2008-03-18),

Company Overview

Cytopeia is a leading biotechnology company that specializes in developing cutting-edge cell analysis tools. With a focus on flow cytometry technology, Cytopeia's innovative products help researchers and scientists around the world advance their research in fields such as immunology, oncology, and drug discovery. The company's high-quality instruments and reagents offer superior performance and reliability, making Cytopeia a trusted partner in the life sciences industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

4 Patents

#423 in Seattle, WA

#1,466 in Washington

#60,778 in US

Seattle, WA, United States of America

Cytopeia

Forward Citations = 16

2 inventors:

Ger Van Den Engh (3 out of 15 patents)

Gerrit Jan Van Den Engh (1 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytopeia. Retrieved from https://idiyas.com/company/cytopeia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]